Fig. 7From: Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trialsESRD: Effects of immunosuppressive agents on end-stage renal disease in patients with IgAN. CI, confidence interval; RR, relative riskBack to article page